Workflow
颖泰生物: 股票解除限售公告

Summary of Key Points Core Viewpoint - The company, Beijing Yingtai Jiahe Biotechnology Co., Ltd., announced the lifting of restrictions on the sale of 6,002,500 shares, which represents 0.49% of the total share capital [1]. Details of Restricted Stock Release - The total number of shares released from restrictions is 6,002,500 shares, accounting for 0.49% of the company's total share capital of 1,225,800,000 shares [2]. - The reasons for the release of restrictions include annual releases for directors, supervisors, and senior management, as well as releases due to the departure of these individuals [2]. Post-Release Share Capital Situation - After the release of restrictions, the total number of unrestricted shares is 1,207,582,500, which constitutes 98.51% of the total share capital [2]. - The total number of restricted shares remaining is 18,217,500, representing 1.49% of the total share capital [2]. Other Relevant Information - There are no outstanding commitments from the shareholders applying for the release of restrictions [2]. - There are no non-operational fund occupations by the shareholders applying for the release of restrictions [2]. - The company has confirmed that there are no violations or guarantees that could harm the company's interests related to the shareholders applying for the release [2].